A risk model for osteoporotic fractures reusing CT images acquired for other medical reasons

ISRCTN ISRCTN72750412
DOI https://doi.org/10.1186/ISRCTN72750412
ClinicalTrials.gov (NCT) Nil known
Clinical Trials Information System (CTIS) Nil known
Protocol serial number Nil known
Sponsors Geneva University Hospitals and Faculty of Medicine, University of Bern
Funder Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Submission date
04/11/2025
Registration date
17/11/2025
Last edited
05/11/2025
Recruitment status
No longer recruiting
Overall study status
Ongoing
Condition category
Injury, Occupational Diseases, Poisoning
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Osteoporosis (OP) is a silent metabolic bone disease resulting in reduced bone mass and leading to increased rates of bone fragility fractures. OP becomes a major challenge for the quality of life and health care costs of our ageing populations. Areal bone mineral density (aBMD) measured by dual energy x-ray absorptiometry (DXA) is the current standard for diagnosis of OP, but this surrogate of bone strength shows limited sensitivity in predicting fragility fractures. In addition, OP is widely under-diagnosed, and the current fracture risk calculators do not or only partially account for a personalised risk of falls and severity of impact. Accordingly, new strategies and new tools to identify patients at high risk of fractures must urgently be explored. The aim of this project was to develop an integrative fragility fracture prediction model and to validate it with a computer tomography (CT) recycling paradigm that exploits CT examinations of the senior population performed for other medical purposes.
In order to develop and validate the required methods and models, a clinical study that assesses the required variables for fall and fracture risk was conducted.

Who can participate?
Community-dwelling older adults aged 65 years and older who underwent a CT scan at one of the study centers that includes the hip region can participate.

What does the study involve?
The study involves a baseline examination (DXA, HR-pQCT in subgroup, physical performance assessment, questionnaire about daily life and medical history) as well as a follow-up period of 3 years during which incident falls and fractures are recorded via phone calls.

What are the possible benefits and risks of participating?
Individuals who participate in the study benefit from a standard osteoporosis assessment that includes a DXA scan and its evaluation by a medical doctor. No particular risks are expected.

Where is the study run from?
The study was run at two medical centers as well as one academic institution:
1) Service of Bone Diseases, Department of Internal Medicine Specialties, Geneva University Hospital, Switzerland
2) Department of Osteoporosis, Inselspital Bern, University Hospital Bern, Switzerland
3) ARTORG Center for Biomedical Engineering Research, University of Bern, Bern, Switzerland

When is the study starting and how long is it expected to run for?
The first participants were enrolled in February 2021, and the last follow-up calls will be completed by the end of June 2026.

Who is funding the study?
This study is funded by the Swiss National Science Foundation (SNF), grant number 1383584.

Who is the main contact?
christina.wapp@unibe.ch

Contact information

Dr Christina Wapp
Public, Scientific

Freiburgstrasse 3
Bern
3010
Switzerland

ORCiD logoORCID ID 0009-0006-2476-2941
Email christina.wapp@unibe.ch
Prof Philippe Zysset
Principal investigator

Freiburgstrasse 3
Bern
3010
Switzerland

ORCiD logoORCID ID 0000-0002-4712-7047
Phone +41 31 684 14 87
Email philippe.zysset@unibe.ch
Prof Serge Ferrari
Principal investigator

Avenue de la Roseraie 64
Bâtiment de Recherches Médicales
Genève
1205
Switzerland

ORCiD logoORCID ID 0000-0002-1372-4417
Phone +41 22 379 46 72
Email serge.ferrari@unige.ch

Study information

Primary study designObservational
Study designMulticenter observational cohort study
Secondary study designCohort study
Participant information sheet 48384_Studieninformation_HFV_Kap_2_d_V4.pdf
Scientific titleA fragility fracture integrative risk model using CT recycling
Study acronymAFFIRM-CT
Study objectivesThe overall aim of the AFFIRM-CT project was to develop a mechanistic risk model for hip fracture prediction. In this study, bone densitometry as well as risk factors for falls and fragility fractures were assessed.
Ethics approval(s)

Approved 22/07/2020, Commission cantonale d'éthique de la recherche (CCER) Geneve (Rue Adrien-Lachenal 8, Genève, 1207, Switzerland; +41 22 54 65 101; ccer@etat.ge.ch), ref: 2019-01327

Health condition(s) or problem(s) studiedFragility fractures and falls in community-dwelling older adults
InterventionCommunity-dwelling older adults aged 65 years and older who underwent an abdominal CT scan that included the hip were eligible to participate in the study. Enrolled participants were invited for a single visit to the respective medical centre. During the visit, participants underwent DXA scans of the lumbar spine and hip. At the same time, various variables in the field of medical history, cognitive status and physical performance were assessed. A subgroup was undergoing HR-pQCT scans of the distal tibia and radius. After the examination, individuals were followed up for 36 months, and phone calls were made to assess incident falls and fractures.
Intervention typeOther
Primary outcome measure(s)

1. Incident falls, prospectively recorded via phone calls during 3 years of follow-up
2. Incident fragility fractures, prospectively recorded via phone calls during 3 years of follow-up

Key secondary outcome measure(s)

Measured using patient records (unless otherwise noted) at baseline:
1. Bone imaging modalities:
1.1 Bone mineral density using DXA (lumbar spine, hip)
1.2 Bone microstructure and strength using high-resolution peripheral computerised quantitative tomography (HR-pQCT) images at distal radius and tibia (substudy)
2. Medical history:
2.1 Comorbidities
2.2 Medication
2.3 Falls during the 6 months prior to baseline examination
2.4 History of fractures (all-life)
3. Fall risk factors:
3.1 Physical performance tests (Short physical performance battery (SPPB), hand grip strength, timed up and go)
3.2 Vision acuity with SZB Bailey-Lovie chart
3.3 Physical activity measured with wrist-worn accelerometer (Axivity) and questionnaire
3.4 Cognitive status measured with Mini Mental State Examination (MMSE)
3.5 Fear of falling measured with Falls Efficacy Scale international (FES-I) and questionnaire
4. Soft tissue stiffness measurement over the gerater trochanter performed with the Myoton indentation device

Completion date30/06/2026

Eligibility

Participant type(s)Patient, Other
Age groupSenior
Lower age limit65 Years
Upper age limit105 Years
SexAll
Target sample size at registration800
Total final enrolment372
Key inclusion criteria1. Individuals aged 65 years and older
2. Community-dwelling older adult
3. Having obtained an abdominal CT including the hip (lesser trochanter of the femur visible)
Key exclusion criteria1. Aged <65 years or having a life expectancy of <1 year
2. Nursing home resident
3. Prior hip fracture or hip prosthesis, unilateral or bilateral
4. Suffering from a bone pathology such as bone metastatic cancer, multiple myeloma, Paget's disease, osteogenesis imperfecta
5. Permanently bedridden or in a wheel-chair
6. Have cognitive impairment with incapacity to provide informed consent
Date of first enrolment01/02/2021
Date of final enrolment30/06/2023

Locations

Countries of recruitment

  • Switzerland

Study participating centres

University Hospital Bern, Policlinics for Osteoporosis
Imhoof-Pavillon
Bern
3010
Switzerland
Service of Bone Diseases, Department of Internal Medicine Specialties, Geneva University Hospital
4 Rue Gabrielle Perret-Gentil
Geneva 14
1211
Switzerland
ARTORG Center for Biomedical Engineering Research
Freiburgstrasse 3
Bern
3010
Switzerland

Results and Publications

Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryStored in publicly available repository
IPD sharing planThe data set is currently in preparation to be published on Zenodo.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet in German
version 4
05/11/2025 No Yes
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes

Additional files

48384_Studieninformation_HFV_Kap_2_d_V4.pdf
in German

Editorial Notes

04/11/2025: Trial's existence confirmed by Commission cantonale d'éthique de la recherche (CCER) Geneve.